Volume Surge: StemCells, Inc. (STEM)

Posted in pre-market 
June 8th, 2009

StemCells, Inc. (NASDAQ: STEM) ius surging on news of a positive Phase 1 trial of six patients with Batten Disease.  Shares are trading up on over 350,000 shares as of 8:22 AM EST by 13% at $1.98.  Its average volume is 2.7 million shares.  FULL DATA on the results is at BioHealthInvestor.com. -JCO

Comments are closed